Figure 1
From: Toxicity evaluation of zinc aluminium levodopa nanocomposite via oral route in repeated dose study
Average weight gain with time. The bar chart showed average weight of rats per group at days 0, 7, 14 and 21 of sub-acute toxicity study. There is an obvious increase in the animal's weight; it is shown to be continuous in the four treatment groups as well as the vehicle control. Zinc-aluminium levodopa nanocomposite high dose (ZALH 500 mg/kg), zinc-aluminium levodopa nanocomposite low dose (ZALL 5 mg/kg), zinc-aluminium nanocomposite high dose (ZAH 500 mg/kg), zinc-aluminium nanocomposite low dose (ZAL 5 mg/kg), vehicle control (VC normal saline 100 ml/kg body weight). There is statistically significant difference (#) between day 0 and all other days in all the groups (p < 0.05). One-way ANOVA was used, and data are expressed as means ± SD.